Jane Street’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.8M Sell
31,000
-16,800
-35% -$1.54M ﹤0.01% 4467
2025
Q4
$4.3M Buy
47,800
+25,900
+118% +$2.46M ﹤0.01% 3465
2025
Q3
$2.16M Sell
21,900
-5,600
-20% -$555K ﹤0.01% 4800
2025
Q2
$2.51M Buy
27,500
+24,300
+759% +$2.35M ﹤0.01% 4061
2025
Q1
$362K Sell
3,200
-9,900
-76% -$1.06M ﹤0.01% 7487
2024
Q4
$1.38M Sell
13,100
-24,100
-65% -$2.59M ﹤0.01% 4806
2024
Q3
$4.02M Buy
37,200
+35,300
+1,858% +$3.85M ﹤0.01% 3219
2024
Q2
$206K Sell
1,900
-5,500
-74% -$648K ﹤0.01% 8334
2024
Q1
$977K Sell
7,400
-1,600
-18% -$200K ﹤0.01% 5463
2023
Q4
$1.1M Sell
9,000
-14,100
-61% -$1.57M ﹤0.01% 5399
2023
Q3
$2.59M Buy
23,100
+12,400
+116% +$1.57M ﹤0.01% 3602
2023
Q2
$1.56M Buy
+10,700
New +$1.45M ﹤0.01% 4532
2022
Q4
Sell
-62,100
Closed -$6.49M 10297
2022
Q3
$6.49M Buy
62,100
+54,300
+696% +$5.96M ﹤0.01% 2227
2022
Q2
$819K Sell
7,800
-43,000
-85% -$5.1M ﹤0.01% 5849
2022
Q1
$6.5M Buy
50,800
+3,626
+8% +$437K ﹤0.01% 2606
2021
Q4
$5.82M Sell
47,174
-22,969
-33% -$3.01M ﹤0.01% 2619
2021
Q3
$9.97M Buy
70,143
+49,234
+235% +$7.24M ﹤0.01% 1811
2021
Q2
$3.27M Sell
20,909
-13,184
-39% -$2.14M ﹤0.01% 3421
2021
Q1
$5.3M Buy
34,093
+23,484
+221% +$3.64M ﹤0.01% 2327
2020
Q4
$1.59M Sell
10,609
-28,634
-73% -$4.04M ﹤0.01% 3921
2020
Q3
$5.19M Sell
39,243
-15,862
-29% -$2.07M ﹤0.01% 1810
2020
Q2
$6.39M Buy
55,105
+30,591
+125% +$3.53M ﹤0.01% 1576
2020
Q1
$2.41M Buy
+24,514
New +$3.21M ﹤0.01% 1835
2019
Q2
Sell
-61,800
Closed -$7.66M 5859
2019
Q1
$7.66M Sell
61,800
-103
-0.2% -$11.7K 0.01% 841
2018
Q4
$6.23M Buy
+61,903
New +$6.96M 0.01% 804
2016
Q3
Sell
-2,163
Closed -$253K 4639
2016
Q2
$253K Buy
+2,163
New +$245K ﹤0.01% 3507

Other funds holding ZBH

Jane Street's ZBH Position: Q1 2026 in Review

Jane Street sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 4,607 shares — an estimated $423K sold.

Jane Street first reported a position in ZBH in Q4 2013 and held it in 41 quarters. The position peaked at $22.7M in Q4 2024. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Jane Street reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 4,607 Zimmer Biomet shares in Q1 2026, an estimated $423K.
  • Jane Street first reported a position in Zimmer Biomet in Q4 2013 and held it in 41 quarters.
  • Jane Street's Zimmer Biomet position peaked at $22.7M in Q4 2024.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.